News
What Is NMN and Why It’s Becoming More and More Important?
Growing old is inevitable. However, it is possible to reverse the aging process using Nicotinamide Mononucleotide or NMN. Keeping that in mind, I'm going to give you the details of how this molecule works in cells.
What Is NMN?
One of...
News
National Database of Drug Formulations In India A Priority
In an effort to better inform and empower consumers, the Indian government has announced plans to create a comprehensive database on every medicinal composition supplied there.
The Ministry of Health and Family Welfare (MoHFW) of India announced plans to compile...
Drug Research
An Encrypt Medicine Suppresses COVID-19 And Its Variants
Dana-Farber scientists have developed a medication that neutralises SARS-CoV-2, the COVID-19 coronavirus, and every other tested version. The medicine is developed so that natural selection maintains its activity against future viral strains.
The investigational medicine is not an antibody but...
News
$5Bn Pharmaceutical Cooperation For Bispecific Antibodies
Ivonescimab (PD-1/VEGF, AK112), a ground-breaking bispecific antibody, will be out-licensed by Biopharma Akeso Inc. to Summit Therapeutics Inc. for use in research and development and commercialization in the US, Canada, Europe, and Japan. This agreement might be worth up...
News
Curing Cholestatic Liver Disease After Cognitive Impairment
Cholestatic Bile flow can be hampered by liver conditions like primary biliary cholangitis (PBC), which can result in neurological problems.
There is presently no known cure for the ailment, and the causes of the onset of such neurological symptoms are...
News
3D COF Shows Good Hydrogen, CO2, And Methane Adsorption
In order to provide effective, extended-release medication delivery, Japanese researchers have developed TUS-84, a new three-dimensional (3D) covalent organic framework (COF) having a scu-c topology for the first time. The research was published in Applied Materials & Interfaces by...
Industry Reports
Top Biopharma Companies Show A Dip In Market Cap For Q3
The market capitalization of the top 20 biopharmaceutical businesses worldwide has decreased by 9.1%, from $3.45 trillion in Q2 2022 to $3.14 trillion in Q3 2022, as a result of growing generic competition and a decline in demand for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read